1. Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-1 but does not acutely stimulate serum GH;Thorner;J. Clin. Endocrinol. Metab.,1999
2. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist;Van der Lely;Lancet,2001
3. The place of pegvisomant in the management of acromegaly;Parkinson;Expert Opin. Investig. Drugs,2001
4. The future of growth hormone antagonists;Van der Lely;Curr. Opin. Pharmacol.,2002